We are proud to announce that PhenoPath is now a Quest Diagnostics Company.


Concordance between human epidermal growth factor receptor 2 testing by reverse transcriptase polymerase chain reaction and fluorescent in situ hybridization.

By Gown AM, Goldstein LC, Hwang HC, Tse CH.

J Clin Oncol. 2012 May 10;30(14):1726-7; author reply 1728-9. doi: 10.1200/JCO.2011.41.0092. Epub 2012 Apr 9.

Abstract not available.

PMID: 22493420 [PubMed - indexed for MEDLINE]

View full article on Journal of Clinical Oncology >